NeuroOne Medical | 4:持股变动声明-高管 Mertens Steve
NeuroOne Medical | 4:持股变动声明-高管 Christianson Mark
NeuroOne Medical | 4:持股变动声明-高管 Rosa David A
NeuroOne Medical | 4:持股变动声明-高管 Mertens Steve
NeuroOne Medical | 4:持股变动声明-高管 Christianson Mark
NeuroOne Medical | 4:持股变动声明-高管 Rosa David A
NeuroOne Medical | 4:持股变动声明-高管 Mertens Steve
NeuroOne Medical | 4:持股变动声明-高管 Christianson Mark
NeuroOne Medical | 4:持股变动声明-高管 Rosa David A
NeuroOne Medical | 4:持股变动声明-高管 Mertens Steve
NeuroOne Medical | 4:持股变动声明-高管 Rosa David A
NeuroOne Medical | 4:持股变动声明-高管 Christianson Mark
NeuroOne Medical | 4:持股变动声明-高管 Mertens Steve
NeuroOne Medical | 4:持股变动声明-高管 McClurg Ronald W.
NeuroOne Medical | 4:持股变动声明-高管 Christianson Mark
NeuroOne Medical | 4:持股变动声明-高管 Rosa David A
NeuroOne Medical | SC 13G:超过5%持股股东披露文件-Nantahala Capital Management, LLC(5.1%),Wilmot B. Harkey(5.1%)等
NeuroOne Medical | 4:持股变动声明-高管 Mertens Steve
NeuroOne Medical | 4:持股变动声明-高管 Christianson Mark
NeuroOne Medical | 4:持股变动声明-高管 Rosa David A
暂无数据